Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Asper Biotech, BioData

Premium

Illumina has begun selling a third generation of its mutation-linkage panel, a genome-wide set of SNP markers and validated assays. The panel is available either as part of a fast-track SNP-genotyping service or as a standard product for research centers already armed with a BeadArray genotyping instrument, Illumina said.

The Linkage Panell III, which can interrogate more than 4,600 SNP loci across the genome, is “ideally suited” for family-based genetic linkage studies.

Illumina’s BeadArray technology and GoldenGate assay protocol enable 96-well, plate-based sample handling and parallel analysis of more than 1,200 SNP markers per well, and nearly 120,000 genotypes per plate.


Estonian SNP-genotyping company Asper Biotech and BioData, an informatics shop, have jointly launched SNP Assistant for SNP management, validation, and analysis.

The technology, which is not platform dependent, enables researchers to perform marker and sample preparation; case control and TDT tests; ID calculation; relationship tests; and database comparisons, the companies said.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.